FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118395771> ?p ?o ?g. }

• W3118395771 abstract "Recent findings suggested that Clinical Endocannabinoid Deficiency underlies the pathophysiology of pain disorders, including migraine and headache. In models of medication overuse headache induced by sustained administration of sumatriptan or morphine, 2-AG levels were selectively depleted in the periaqueductal gray (PAG) and anandamide (AEA) increased in the cortex suggesting distinct regulation of the endocannabinoid system during headache pain. These results led to the hypothesis that blockade of DAGL, to reduce 2-AG levels would induce headache-like behaviors as a new, translationally relevant model of episodic headache. Our study investigated whether non-selective and selective blockade of DAGL, the main biosynthetic enzyme for 2-AG, induced periorbital and hind-paw allodynia, photophobia, anxiety-like behaviors, responsivity to abortive anti-migraine agents, and 2-AG/AEA levels. Injection of non-selective DAGL (DH376, 10 mg/kg, IP) and selective DAGLα (LEI106, 20 mg/kg, IP) inhibitors, but not DAGLβ agents, induced facial sensitivity in 100% and ∼60% of female and male rats, respectively, without induction of peripheral sensitivity. Notably, male rats showed significantly less sensitivity than female rats after DAGLα inhibition, suggesting sexual dimorphism in this mechanism. Importantly, LEI106 induced periorbital allodynia was attenuated by administration of the clinically available abortive antimigraine agents, sumatriptan and olcegepant. Selective DAGLα inhibition induced significant photophobia as measured by the light-dark box, without anxiety like behaviors or changes in voluntary movement. Analysis of AEA and 2-AG levels at the time of peak pain sensitivity revealed reductions in 2-AG in the visual cortex and periaqueductal gray (PAG), without altering anandamide or significantly increasing diacylglycerol levels. These results provide foundational evidence for DAGL-2AG in the induction of headache-like pain and photophobia without extracephalic allodynia, thus modeling the clinical episodic migraine. Mechanistically, behavioral measures of headache sensitivity after DAGL inhibition suggests that reduced 2-AG signaling in the cortex and PAG, but not the trigeminal nucleus caudalis or trigeminal ganglia, drives headache initiation. Therefore, episodic DAGL inhibition, which reduces the time, cost, and invasiveness of currently accepted models of headache, may fill the need for episodic migraine/headache models mirroring clinical presentation. Moreover, use of this approach may provide an avenue to study the transition from episodic to chronic headache." @default.
• W3118395771 created "2021-01-18" @default.
• W3118395771 creator A5009768215 @default.
• W3118395771 creator A5017503792 @default.
• W3118395771 creator A5021165910 @default.
• W3118395771 creator A5051400136 @default.
• W3118395771 creator A5070943117 @default.
• W3118395771 creator A5086900956 @default.
• W3118395771 creator A5087823012 @default.
• W3118395771 date "2021-01-12" @default.
• W3118395771 modified "2023-09-26" @default.
• W3118395771 title "DAGLα Inhibition as a Non-invasive and Translational Model of Episodic Headache" @default.
• W3118395771 cites W1550754406 @default.
• W3118395771 cites W1600237922 @default.
• W3118395771 cites W1938154749 @default.
• W3118395771 cites W1964771054 @default.
• W3118395771 cites W1968459206 @default.
• W3118395771 cites W1988662090 @default.
• W3118395771 cites W1995320093 @default.
• W3118395771 cites W1998057663 @default.
• W3118395771 cites W1998472195 @default.
• W3118395771 cites W2013799561 @default.
• W3118395771 cites W2016327412 @default.
• W3118395771 cites W2022180074 @default.
• W3118395771 cites W2032593044 @default.
• W3118395771 cites W2035768389 @default.
• W3118395771 cites W2040634905 @default.
• W3118395771 cites W2041094930 @default.
• W3118395771 cites W2056031943 @default.
• W3118395771 cites W2066034429 @default.
• W3118395771 cites W2068200582 @default.
• W3118395771 cites W2072800583 @default.
• W3118395771 cites W2094028391 @default.
• W3118395771 cites W2097107346 @default.
• W3118395771 cites W2103351070 @default.
• W3118395771 cites W2103477492 @default.
• W3118395771 cites W2110106197 @default.
• W3118395771 cites W2116754069 @default.
• W3118395771 cites W2123514356 @default.
• W3118395771 cites W2128912408 @default.
• W3118395771 cites W2132318642 @default.
• W3118395771 cites W2134450626 @default.
• W3118395771 cites W2136164241 @default.
• W3118395771 cites W2162104155 @default.
• W3118395771 cites W2163386604 @default.
• W3118395771 cites W2164973029 @default.
• W3118395771 cites W2216267918 @default.
• W3118395771 cites W2237245576 @default.
• W3118395771 cites W2301252870 @default.
• W3118395771 cites W2323702705 @default.
• W3118395771 cites W2336815228 @default.
• W3118395771 cites W2460083407 @default.
• W3118395771 cites W2460306499 @default.
• W3118395771 cites W2515727339 @default.
• W3118395771 cites W2586533881 @default.
• W3118395771 cites W2607203908 @default.
• W3118395771 cites W2610948542 @default.
• W3118395771 cites W2626577148 @default.
• W3118395771 cites W2743089454 @default.
• W3118395771 cites W2748951628 @default.
• W3118395771 cites W2769681853 @default.
• W3118395771 cites W2789353908 @default.
• W3118395771 cites W2790367203 @default.
• W3118395771 cites W2792631809 @default.
• W3118395771 cites W2801085490 @default.
• W3118395771 cites W2883802793 @default.
• W3118395771 cites W2896165905 @default.
• W3118395771 cites W2911947360 @default.
• W3118395771 cites W2925299340 @default.
• W3118395771 cites W2971348120 @default.
• W3118395771 cites W2973889334 @default.
• W3118395771 cites W2981126640 @default.
• W3118395771 cites W2985224477 @default.
• W3118395771 cites W3096147069 @default.
• W3118395771 cites W94215450 @default.
• W3118395771 doi "https://doi.org/10.3389/fphar.2020.615028" @default.
• W3118395771 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7874129" @default.
• W3118395771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33584293" @default.
• W3118395771 hasPublicationYear "2021" @default.
• W3118395771 type Work @default.
• W3118395771 sameAs 3118395771 @default.
• W3118395771 citedByCount "9" @default.
• W3118395771 countsByYear W31183957712021 @default.
• W3118395771 countsByYear W31183957712022 @default.
• W3118395771 countsByYear W31183957712023 @default.
• W3118395771 crossrefType "journal-article" @default.
• W3118395771 hasAuthorship W3118395771A5009768215 @default.
• W3118395771 hasAuthorship W3118395771A5017503792 @default.
• W3118395771 hasAuthorship W3118395771A5021165910 @default.
• W3118395771 hasAuthorship W3118395771A5051400136 @default.
• W3118395771 hasAuthorship W3118395771A5070943117 @default.
• W3118395771 hasAuthorship W3118395771A5086900956 @default.
• W3118395771 hasAuthorship W3118395771A5087823012 @default.
• W3118395771 hasBestOaLocation W31183957711 @default.
• W3118395771 hasConcept C126322002 @default.
• W3118395771 hasConcept C134018914 @default.
• W3118395771 hasConcept C141071460 @default.
• W3118395771 hasConcept C15490471 @default.
• W3118395771 hasConcept C170493617 @default.
• W3118395771 hasConcept C2777883359 @default.

• next